Cargando…

Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer—a two center experience

PURPOSE: Integrating moderate hypofractionation to the macroscopic tumor with elective nodal irradiation while sparing the organs at risk (OAR) in chemoradiotherapy of locally advanced non-small-cell lung cancer. METHODS: From 2010–2018, treatment, patient and tumor characteristics of 138 patients f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantel, Frederick, Müller, Elena, Kleine, Philip, Zimmermann, Marcus, Exner, Florian, Richter, Anne, Weick, Stefan, Ströhle, Serge, Polat, Bülent, Höcht, Stefan, Flentje, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062353/ https://www.ncbi.nlm.nih.gov/pubmed/33725133 http://dx.doi.org/10.1007/s00066-021-01756-7

Ejemplares similares

Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center
por: Zimmermann, Marcus, et al.
Publicado: (2022)

Non-rigid image registration of 4D-MRI data for improved delineation of moving tumors
por: Weick, Stefan, et al.
Publicado: (2020)

Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
por: Kraft, Johannes, et al.
Publicado: (2022)

Comparison of treatment plans for hypofractionated high‐dose prostate cancer radiotherapy using the Varian Halcyon and the Elekta Synergy platforms
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Impact of beam configuration on VMAT plan quality for Pinnacle(3)Auto-Planning for head and neck cases
por: Richter, Anne, et al.
Publicado: (2019)

Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer
por: Richter, Anne, et al.
Publicado: (2016)

Evaluation of a software module for adaptive treatment planning and re-irradiation
por: Richter, Anne, et al.
Publicado: (2017)

Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems
por: Richter, Anne, et al.
Publicado: (2021)

Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2022)

Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer
por: Tamihardja, Jörg, et al.
Publicado: (2021)

Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
por: Tamihardja, Jörg, et al.
Publicado: (2020)

Impact of Radiotherapy on Malfunctions and Battery Life of Cardiac Implantable Electronic Devices in Cancer Patients
por: Lisowski, Dominik, et al.
Publicado: (2023)

Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma
por: Polat, Bülent, et al.
Publicado: (2022)

Stereotactic body radiation therapy in the re-irradiation situation – a review
por: Mantel, Frederick, et al.
Publicado: (2013)

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma
por: Shi, Zhenguo, et al.
Publicado: (2022)

Multimodal treatment in oligometastatic gastric cancer
por: Chevallay, Mickael, et al.
Publicado: (2022)

Properties of the anisotropy of dose contributions: A planning study on prostate cases
por: Greber, Johannes, et al.
Publicado: (2018)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
por: Stoian, Raluca, et al.
Publicado: (2023)

A prospective study on histone γ-H2AX and 53BP1 foci expression in rectal carcinoma patients: correlation with radiation therapy-induced outcome
por: Djuzenova, Cholpon S., et al.
Publicado: (2015)

Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases
por: Holubyev, Kostyantyn, et al.
Publicado: (2013)

Neoadjuvant Chemoradiotherapy With Simultaneous Integrated Boost in Locally Advanced Cervical Cancer: Long Term Results of a Single-Center Experience
por: Nardangeli, Alessia, et al.
Publicado: (2022)

Oligometastatic Prostate Cancer
por: Stevens, Daniel J., et al.
Publicado: (2016)

Imaging of Oligometastatic Disease
por: Vietti Violi, Naik, et al.
Publicado: (2022)

Dosimetric evaluation of a spinal cord dose‐limiting 3D‐CRT technique for radiotherapy of spinal metastases
por: Arnold, Christian Cornelius, et al.
Publicado: (2023)

Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions
por: Kuger, Sebastian, et al.
Publicado: (2014)

The results of nasopharyngeal cancer patients treated by simultaneous integrated boost technique and concomitant chemotherapy
por: CETİNDAĞ, Mehmet Faik, et al.
Publicado: (2019)

Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
por: Bae, Bong Kyung, et al.
Publicado: (2017)

Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer
por: Oh, Eun Sang, et al.
Publicado: (2018)

Preoperative Intensity-modulated Chemoradiotherapy with Simultaneous Integrated Boost in Rectal Cancer: Five-year Follow-up Results of a Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2021)

How to handle oligometastatic disease in nonsmall cell lung cancer
por: Eichhorn, Florian, et al.
Publicado: (2021)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

The biology and treatment of oligometastatic cancer
por: Reyes, Diane K., et al.
Publicado: (2015)

Radiotherapy for Oligometastatic Lung Cancer
por: Bergsma, Derek P., et al.
Publicado: (2017)

Highlights on the Management of Oligometastatic Disease
por: Alshehri, Salem M., et al.
Publicado: (2020)

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
por: Damanakis, Alexander I., et al.
Publicado: (2019)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease
por: Mehrens, Dirk, et al.
Publicado: (2021)

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer: Statement from the DEGRO working group prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2020)

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study
por: Engels, Benedikt, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_81e4igmkodfofekbfei2ghmj6k